Results 161 to 170 of about 475,290 (309)
Anatomic and Physiologic Effects of the Antithyroid Drug, Propylthiouracil, on Rats
A. James Shold
openalex +1 more source
ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo +9 more
wiley +1 more source
Coronary Sinus Reduction for Refractory Angina Caused by Microvascular Dysfunction-A Systematic Review. [PDF]
Tomaniak M, Bednarek A, Włodarczak A.
europepmc +1 more source
Increased Blood Levels of NfL, GFAP, and Placental Growth Factor After Radiotherapy to the Brain
ABSTRACT In this study, we analyzed biomarkers of neuronal, glial, and vascular injury in longitudinal paired samples of blood and cerebrospinal fluid after prophylactic cranial irradiation in patients with small cell lung cancer. Neurofilament light chain protein (NfL) and glial fibrillary acidic protein (GFAP) increased in serum and cerebrospinal ...
Erik Fernström +5 more
wiley +1 more source
Research progress and application prospect of engineered small extracellular vesicles. [PDF]
Zhang H, Chen J, Tang X, Liu X, Li Z.
europepmc +1 more source
Blocking drug activation as a therapeutic strategy to attenuate acute toxicity and physiological effects of heroin [PDF]
Ting Zhang +4 more
openalex +1 more source
Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability
ABSTRACT Background Myasthenia gravis (MG) is a rare, autoimmune disorder characterized by fluctuating muscle weakness and potential life‐threatening crises. While continuous specialized care is essential, access barriers often delay timely interventions. To address this, we developed MyaLink, a telemedical platform for MG patients.
Maike Stein +13 more
wiley +1 more source
A Mechanism-Based Multi-Level Population PK/PD Model for Potassium-Competitive Acid Blockers. [PDF]
Jung W +6 more
europepmc +1 more source

